Healthpeak Properties, Inc. (NYSE:DOC) Shares Purchased by Candriam S.C.A.

Candriam S.C.A. lifted its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 13.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,949 shares of the real estate investment trust's stock after buying an additional 12,966 shares during the quarter. Candriam S.C.A.'s holdings in Healthpeak Properties were worth $2,249,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at approximately $1,093,576,000. JPMorgan Chase & Co. increased its position in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after purchasing an additional 17,314,572 shares during the last quarter. Geode Capital Management LLC bought a new position in Healthpeak Properties in the 3rd quarter valued at $403,898,000. Finally, Charles Schwab Investment Management Inc. grew its position in Healthpeak Properties by 0.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust's stock valued at $205,810,000 after acquiring an additional 53,392 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Remove Ads

Healthpeak Properties Trading Down 0.9 %

NYSE:DOC traded down $0.17 on Thursday, reaching $20.03. The company's stock had a trading volume of 3,846,633 shares, compared to its average volume of 4,725,047. Healthpeak Properties, Inc. has a 12-month low of $16.66 and a 12-month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market cap of $14.01 billion, a price-to-earnings ratio of 57.22, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The stock has a 50 day moving average price of $20.21 and a 200 day moving average price of $21.26.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were paid a $0.305 dividend. The ex-dividend date was Friday, February 14th. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.09%. Healthpeak Properties's payout ratio is presently 348.57%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on DOC shares. Scotiabank dropped their price target on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research report on Friday, February 28th. Wells Fargo & Company decreased their price target on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 10th. Robert W. Baird reduced their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. Finally, Mizuho dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.